ClinicalTrials.gg
Sign In
Drug

Intranasal Ketamine clinical trials

studies test it
25
open now
3
in phase 3
5
first study started
2001

How each study uses Intranasal Ketamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Intranasal Ketamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Intranasal ketamine
21
PMI-150 (intranasal ketamine)
2
Ketamine
2

Studies by the year they started

25 studies that test it; most in 2007 (5)

Studies that test Intranasal Ketamine, by start year
YearStudies
20011
20075
20081
20142
20151
20163
20172
20181
20191
20201
20211
20232
20241
20252
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
6
Phase 2
7
Phase 3
5
Phase 4
5
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Pain
3
Depression
2
Lacerations
2
Pain, Postoperative
2
Suicidal Ideation
1
Neoplasms
1
Child Behavior
1
Abscess
1
Caregiver Burden
1
Fractures, Closed
1
Obsessive-Compulsive Disorder
1
Depressive Disorder, Major
1

Who runs them

Industry 6 · Other 19

Javelin Pharmaceuticals (4) · Hospira, now a wholly owned subsidiary of Pfizer (2) · University of Cincinnati (2) · Tanta University (1) · Zagazig University (1) · Centre for Addiction and Mental Health (1) · The University of Texas Health Science Center, Houston (1) · Emory University (1)

Often tested with

Tested in the same studies.

Midazolam (3) · Dexmedetomidine (2) · Lidocaine (1) · Prilocaine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Intranasal Ketamine is the comparator. A study of two new drugs counts under both.

Studies

Open first, then newest update. How each study uses Intranasal Ketamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test Intranasal Ketamine →

Given beside what is tested · 2 — Intranasal Ketamine is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Intranasal Ketamine